Capricor Therapeutics, Inc. (CAPR) is primed for evolution with the beta value of 6.87

investchronicle 93

For the readers interested in the stock health of Capricor Therapeutics, Inc. (CAPR). It is currently valued at $4.73. When the transactions were called off in the previous session, Stock hit the highs of $4.9, after setting-off with the price of $4.81. Company’s stock value dipped to $4.65 during the trading on the day. When the trading was stopped its value was $4.83.

Capricor Therapeutics, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.08 on 04/29/20, with the lowest value was $0.88 for the same time period, recorded on 03/12/20.

Capricor Therapeutics, Inc. (CAPR) full year performance was 42.47%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Capricor Therapeutics, Inc. shares are logging -57.31% during the 52-week period from high price, and 437.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.88 and $11.08.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 649206 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Capricor Therapeutics, Inc. (CAPR) recorded performance in the market was 269.53%, having the revenues showcasing 297.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 69.15M, as it employees total of 16 workers.

Analysts verdict on Capricor Therapeutics, Inc. (CAPR)

According to the data provided on, the moving average of the company in the 100-day period was set at 3.18, with a change in the price was noted +3.17. In a similar fashion, Capricor Therapeutics, Inc. posted a movement of +203.21% for the period of last 100 days, recording 4,109,896 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity. The total Debt to Equity ratio for CAPR is recording 0.35 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.35.

Capricor Therapeutics, Inc. (CAPR): Technical Analysis

Raw Stochastic average of Capricor Therapeutics, Inc. in the period of last 50 days is set at 33.02%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 33.33%. In the last 20 days, the company’s Stochastic %K was 40.10% and its Stochastic %D was recorded 42.80%.

Let’s take a glance in the erstwhile performances of Capricor Therapeutics, Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 269.53%. Additionally, trading for the stock in the period of the last six months notably improved by 307.76%, alongside a boost of 42.47% for the period of the last 12 months. The shares sunk approximately by in the 7-day charts and went down by -7.25% in the period of the last 30 days. Common stock shares were driven by 297.48% during last recorded quarter.